SHOULDER INNOVATIONS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SHOULDER INNOVATIONS, INC. (SI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.68 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.74M shares, a 77.74% decline year-over-year.
- SHOULDER INNOVATIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 12.29M shares.
- SHOULDER INNOVATIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.50M shares, a 86.04% decline from fiscal 2024.
- SHOULDER INNOVATIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 10.77M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.68M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 2.74M shares 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 1.50M shares 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 1.56M shares 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 14.23M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 12.29M shares 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | 10.77M shares 10-K · filed 2026-03-10 | |||
| 2024-09-30 | 10.74M shares 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | 10.59M shares 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |